炎症性腸疾患治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00003491
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

市場概要

炎症性腸疾患 (IBD) は、次のような用語です。消化管の慢性炎症を伴う疾患を説明するために使用されます。 2 つのタイプの IBD には、潰瘍性大腸炎とクローン病が含まれ、通常は重度の下痢、腹痛、疲労、体重減少を伴います。 IBDの治療は、兆候や症状の引き金となる炎症を軽減することです。治療には薬物療法または手術が含まれます。薬物療法には、結腸の患部に応じて、コルチコステロイドやメサラミン (アサコール HD、デルジコールなど)、バルサラジド (コラザール)、オルサラジン (ディペンタム) などのアミノサリチル酸塩をさらに含む抗炎症薬が含まれます。< /p>

市場範囲

“世界的な炎症「2028 年までの腸疾患治療市場分析」

は、世界市場の傾向分析に特に焦点を当てた、医療機器業界の専門的かつ詳細な調査です。このレポートは、薬剤クラスの種類、疾患の適応症、流通チャネル、地理ごとに詳細な市場分割を行い、炎症性腸疾患治療市場の概要を提供することを目的としています。このレポートは、炎症性腸疾患治療市場の主要企業の市場状況に関する重要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション

  • 薬物クラスの種類に基づいて、市場はアミノサリチル酸塩、免疫調節剤、TNF 阻害剤、コルチコステロイドに分類されます。
  • 疾患の適応症に基づいて、市場はクローン病と潰瘍性大腸炎に分類されます
  • 流通チャネルに基づいて、世界の炎症性腸疾患治療市場は病院薬局、オンライン薬局、小売薬局に分類されます。
< p>

市場ダイナミクス

ドライバー:

  • 炎症性腸疾患 (IBD) 治療のための強力なパイプライン製品の存在
  • クローン病と潰瘍性大腸炎の有病率の上昇

制限:

  • 高額な治療費

地域フレームワーク

このレポートは、定性的および定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、市場規模も提供します。北米、欧州、アジア太平洋(APAC)、中東およびアフリカ(MEA)、南米の主要5地域について、2019年から2028年までの予測推計を掲載しています。各地域はその後、それぞれの国とセグメントごとにサブセグメント化されます。レポートでは、世界 18 か国の分析と予測、およびその地域に広がる現在の傾向と機会が取り上げられています。

レポートは、需要側と供給側の両方から市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートでは、北米、欧州、APAC、MEA、南米の 5 つの地域すべてについて、これらの地域の炎症性腸疾患治療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後、徹底的な PEST 分析も提供しています。

炎症性腸疾患治療市場に対する新型コロナウイルス感染症 (COVID-19) の影響

新型コロナウイルス感染症 (COVID-19) は、2019 年 12 月に初めて武漢 (中国) で発生し、それ以来、速いペースで全土に広がりました。米国、インド、ブラジル、ロシア、フランス、英国、トルコ、イタリア、スペインは、感染者数と死亡報告数で最も深刻な影響を受けている国の一部である。新型コロナウイルスのパンデミックにより、炎症性腸疾患の需要が増加している

新型コロナウイルス感染症 19 の状況により、多くの企業がこの病気を予防/治療するための効果的なワクチン、生物製剤、医薬品の開発に注力していました。他の医薬品や生物製剤の開発と製造の減速とサプライチェーンの混乱により、2020 年の市場は困難を目の当たりにしました。さらに、ロックダウンのいくつかの制限により、IBD の子供のケアは最小限の基準に保たれています。緊急性と生物学的製剤の注入を優先し、遠隔医療サービスを実施します。

市場参加者

このレポートでは、有機的および無機的な成長戦略として炎症性腸疾患治療市場の主要な展開について取り上げています。さまざまな企業が製品の発売、製品の承認などの有機的な成長戦略に焦点を当てています。特許やイベントなど、市場で見られた無機的な成長戦略活動は、買収、パートナーシップおよびコラボレーションでした。これらの活動は、市場プレーヤーのビジネスと顧客ベースの拡大への道を切り開きました。炎症性腸疾患治療市場からの市場支払者が期待されています世界市場における炎症性腸疾患治療の需要の高まりにより、将来の大きな成長の機会が期待できます。

このレポートには、炎症性腸疾患治療市場における主要企業の SWOT 分析と市場戦略とともに、主要企業のプロフィールも含まれています。さらに、レポートは、炎症性腸疾患治療市場における主要企業に焦点を当てています。会社概要、コンポーネント、提供されるサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報。

  • ファイザー株式会社
  • Novartis AG
  • JOHNSON and JOHNSON (Janssen Global Services, LLC)
  • AbbVie Inc.
  • 武田薬品工業株式会社
  • アレガン
  • セルジーン株式会社
  • バウシュ ヘルス
  • UCB, Inc.
  • コスモファーマシューティカルズ NV

Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供します。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is inflammatory bowel disease?

Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

What factors drive the Inflammatory Bowel Disease Treatment Market?

The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

Who are the major players in the Inflammatory Bowel Disease Treatment Market?

The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

The List of Companies - Inflammatory Bowel Disease Treatment Market

  1. AbbVie Inc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc
  4. Biogen
  5. Novartis AG
  6. Lilly
  7. UCB S.A.
  8. CELLTRION INC.
  9. Merck & Co., Inc.
  10. Johnson & Johnson Services, Inc.
  11. Mindray Medical International Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports